PRELUDE CAPITAL MANAGEMENT, LLC - CASCADIAN THERAPEUTICS INC ownership

CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 1 filers reported holding CASCADIAN THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CASCADIAN THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$293,00079,1550.02%
Other shareholders
CASCADIAN THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
IFP Advisors, Inc 53$00.00%
View complete list of CASCADIAN THERAPEUTICS INC shareholders